OS Therapies Incorporated (OSTX) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

OS Therapies Incorporated (OSTX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $84.2M, listed on AMEX, employing roughly 4 people, carrying a beta of -1.34 to the broader market. OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Led by Paul A. Romness, public since 2024-08-01.

IV/HV history compares implied volatility to realized volatility over time. No recent options activity for OSTX as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how implied vs realized volatility is reported and how to read the data →